CONMED Total Current Assets 2010-2024 | CNMD

CONMED total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
CONMED Annual Total Current Assets
(Millions of US $)
2023 $616
2022 $581
2021 $460
2020 $417
2019 $397
2018 $374
2017 $357
2016 $331
2015 $360
2014 $381
2013 $372
2012 $349
2011 $357
2010 $350
2009 $326
CONMED Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $641
2024-06-30 $624
2024-03-31 $636
2023-12-31 $616
2023-09-30 $626
2023-06-30 $616
2023-03-31 $610
2022-12-31 $581
2022-09-30 $574
2022-06-30 $577
2022-03-31 $488
2021-12-31 $460
2021-09-30 $443
2021-06-30 $443
2021-03-31 $424
2020-12-31 $417
2020-09-30 $404
2020-06-30 $379
2020-03-31 $393
2019-12-31 $397
2019-09-30 $399
2019-06-30 $397
2019-03-31 $391
2018-12-31 $374
2018-09-30 $363
2018-06-30 $347
2018-03-31 $342
2017-12-31 $357
2017-09-30 $357
2017-06-30 $340
2017-03-31 $334
2016-12-31 $331
2016-09-30 $369
2016-06-30 $371
2016-03-31 $368
2015-12-31 $360
2015-09-30 $384
2015-06-30 $374
2015-03-31 $374
2014-12-31 $381
2014-09-30 $385
2014-06-30 $385
2014-03-31 $368
2013-12-31 $372
2013-09-30 $364
2013-06-30 $359
2013-03-31 $354
2012-12-31 $349
2012-09-30 $345
2012-06-30 $337
2012-03-31 $351
2011-12-31 $357
2011-09-30 $370
2011-06-30 $368
2011-03-31 $358
2010-12-31 $350
2010-09-30 $367
2010-06-30 $349
2010-03-31 $353
2009-12-31 $326
2009-09-30 $316
2009-06-30 $293
2009-03-31 $289
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.215B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49